Perimenopause — the hormonal transition phase that typically begins in the mid-to-late 40s and can last several years before menopause — is one of the most dramatic periods of skin change in adult life, and one of the least prepared for. The combination of fluctuating and declining oestrogen, relative androgen dominance, and accelerating collagen loss produces a cluster of skin changes that can appear to happen simultaneously: sudden dryness after decades of combination skin, adult acne returning for the first time since adolescence, accelerated loss of firmness, and new sensitivity or reactive patterns. The changes are real, driven by specific biology, and respond to targeted skincare intervention — but only if you understand what is actually happening.
During perimenopause, declining oestrogen reduces barrier lipid production, collagen synthesis, and skin's water-binding capacity — causing dryness, thinning, and accelerated fine lines. Simultaneously, relatively elevated androgens can increase sebum and trigger adult acne. The skin becomes more reactive as the barrier thins. The routine response is to significantly increase barrier support (ceramides, panthenol), introduce or intensify retinoids, maintain rigorous SPF, and address acne with non-hormonal approaches (niacinamide, azelaic acid, salicylic acid) rather than drying treatments designed for younger acne.
Oestrogen — primarily oestradiol — plays a significant role in skin physiology. Oestrogen receptors are expressed in keratinocytes, fibroblasts, melanocytes, and sebaceous glands, meaning the skin is directly sensitive to circulating oestrogen levels. During perimenopause, oestrogen levels become erratic (fluctuating unpredictably rather than declining in a straight line) and eventually decline substantially. The effects are systemic and broad.
At the same time, progesterone levels fall, and androgens — while also declining overall in this period — decline more slowly than oestrogen in many people. This creates a window of relative androgen excess, even though absolute androgen levels are lower than they were in youth. The ratio shift toward androgens stimulates sebaceous glands and can trigger acne in people who had clear skin for decades. This hormonal acne pattern — typically presenting on the lower face, jawline, and chin rather than the T-zone — is one of the most confusing aspects of perimenopausal skin because it appears simultaneously with dryness and thinning, which seem contradictory.
| Change | Hormonal Driver | What It Feels/Looks Like |
|---|---|---|
| Accelerated collagen loss | Declining oestrogen — oestrogen stimulates collagen synthesis in fibroblasts | Loss of firmness, deepening lines, thinner overall skin |
| Reduced barrier function | Declining oestrogen — oestrogen supports ceramide and hyaluronic acid production | Increased dryness, tightness, sensitivity, slower barrier recovery |
| Adult hormonal acne | Relative androgen dominance — androgens stimulate sebaceous activity | Deep, often cystic breakouts on jawline, chin, lower cheeks |
| Increased skin sensitivity | Thinning barrier + altered immune regulation | New reactions to products that were previously tolerated; redness; stinging |
| Changes in pigmentation | Declining oestrogen after years of hormonal stimulation — melasma may improve; sun damage becomes more visible | Melasma may fade; solar lentigines become more apparent |
| Increased facial hair | Relative androgen dominance | Finer facial hair becomes coarser; new growth on chin and upper lip |
The most impactful shift for perimenopausal skin is upgrading the moisturiser from whatever "worked before" to a genuinely rich, ceramide-based formula. Oestrogen decline means the skin is no longer producing the barrier lipids it was, and topical ceramides directly supplement this deficit. A ceramide-rich moisturiser applied AM and PM, with an additional panthenol-containing serum for wound-healing and barrier-repair support, is the foundation around which everything else is built. This also applies to the eye area, where oestrogen-dependent collagen loss is often most visibly accelerated.
If there is one active that perimenopause makes more important rather than less, it is a retinoid. The accelerated collagen loss of the perimenopausal period is the exact target of retinoid-induced collagen stimulation. Starting retinol during perimenopause — or stepping up in concentration if already using it — is the highest-value cosmetic intervention available without a prescription. The barrier thinning that occurs during perimenopause does make the skin more prone to retinol irritation, so the sandwich technique (moisturiser → retinol → moisturiser) and a conservative frequency build are particularly important. See our guide to starting retinol and our mature skin routine guide for the full framework.
The acne of perimenopause is hormonally driven, which means the standard approach for teenage acne — high-percentage salicylic acid cleansers, benzoyl peroxide, drying spot treatments — is wrong for this context. The skin is simultaneously dry and breaking out, and drying approaches worsen the barrier compromise while only partially addressing the acne. The more appropriate approach uses niacinamide (sebum regulation, anti-inflammatory), azelaic acid (antibacterial, anti-inflammatory, with no drying effect), and a low-concentration salicylic acid as a targeted spot treatment rather than an all-over exfoliant. See our guide to acne-prone skin routines for ingredient priorities, then adapt for the dry-barrier context of perimenopause.
With collagen declining faster and the barrier thinner, UV damage causes more visible and more lasting harm during perimenopause than it did previously. Daily broad-spectrum SPF 50 protects the collagen that remains, prevents the photoageing that compounds hormonal skin changes, and is the most important single daily step for skin quality at this life stage. For perimenopausal skin prone to new sensitivity, mineral sunscreens with zinc oxide are often better tolerated than chemical-only formulations.
Oestrogen decline reduces the skin's capacity to produce and retain hyaluronic acid endogenously. Topical HA serums help replace this — but in perimenopausal skin with a compromised barrier, applying HA without a sealing moisturiser on top can paradoxically increase transepidermal water loss in low-humidity environments (the humectant draws water to the surface and the compromised barrier lets it evaporate). Always follow HA serums with a ceramide moisturiser. See our guide to dehydrated vs dry skin for how to stack humectants and occlusives correctly.